Clovis Oncology, Inc. CLVSQ

Market cap
$14.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Sep '22 Jun '22 Mar '22 Dec '21 Older periods
ROE
78.31% 91.63% 98.57% 120.90%

+8 more TTM periods

ROA
(58.94%) (54.57%) (51.66%) (49.06%)
ROIC
0.00% (73.03%) (65.22%) (71.85%)
Return on Tangible Assets
39.31% (997.42%) (370.81%) (333.04%)
Average Days of Receivables
53.38 48.32 68.73 65.93
Free Cash Flow per Share
(1.22) (1.26) (1.40) (1.70)
Free Cash Flow
(175.84) (181.30) (192.92) (196.37)
Piotroski F-Score
2.00 2.00 4.00 3.00
Other line items

Show all line items

Columns are period end dates